Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 41.05.021, 41.05.160; chapter 70.405 RCW, and SSSB [2SSB] 5532, sections 2(6), 4(4), 5(1), 7(3), 9, and 11, chapter 153, Laws of 2022.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: To implement the prescription drug affordability board as required in SSSB [2SSB] 5532, chapter 153, Laws of 2022.

Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Not applicable.

Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Valerie Freudenstein, Rulemaking Questions, 626 8th Avenue S.E., Olympia, WA 98504, phone 360-725-1344, fax 360-586-9727, telecommunication[s] relay service (TRS) 711, email valerie.freudenstein@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking; or Nonye Connor, Program Questions, 626 8th Avenue S.E., Olympia, WA 98504, phone 360-725-2044, fax 360-586-9727, TRS 711, email nonye.connor@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking.